HemaClear by OHK medical devices

HemaClear by OHK Medical Devices is a medical device company based in Haifa, Israel. It focuses on developing innovative, patent-protected single-use devices for orthopedic surgery, vascular surgery, and emergency medicine. The company's flagship product, HemaClear®, is a sterile exsanguination tourniquet that creates a bloodless surgical field by quickly displacing blood from limbs and blocking its re-entry. This device is designed for both upper and lower extremities and is available in various sizes to accommodate patients from infants to obese adults. HemaClear® offers several benefits, including approximately 95% exsanguination, a 100% sterile surgical field, and improved anatomical visibility for surgeons. It reduces the risk of post-operative complications and minimizes pain and skin injury associated with traditional tourniquets. The product has been endorsed by key opinion leaders in medical centers worldwide, with over 1 million procedures performed globally. Additionally, OHK Medical Devices has introduced the EED™ product line for emergency medicine, which auto-transfuses a patient’s own blood during critical situations.

• Employees 26
• Founded 2002
• Annual Revenue $5666000